tiprankstipranks
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
PTX
Prescient Therapeutics Limited
RESEARCH TOOLSreports

Prescient Therapeutics Limited (PTX) Stock News & Sentiment

17 Followers
Prescient Tightens Governance With Updated Securities Trading Policy
Premium
Company Announcements
Prescient Tightens Governance With Updated Securities Trading Policy
1M ago
PTX
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
Premium
Company Announcements
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
2M ago
PTX
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
Premium
Company Announcements
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
2M ago
PTX
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
Premium
Company Announcements
Prescient Therapeutics Issues 21.78m Unquoted Options Under Employee Incentive Plan
4M ago
PTX
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
Premium
Company Announcements
Prescient Therapeutics Gains EU Approval for PTX-100 CTCL Trial
4M ago
PTX
Prescient Therapeutics Announces Director’s Interest Change
Premium
Company Announcements
Prescient Therapeutics Announces Director’s Interest Change
5M ago
PTX
Prescient Therapeutics Announces Director’s Change in Securities Interest
Premium
Company Announcements
Prescient Therapeutics Announces Director’s Change in Securities Interest
5M ago
PTX
More AU:PTX News >

PTX News on the Web

Prescient Therapeutics ramps up Phase 2 trial as research reiterates valuation upside
Proactive Investors
Bullish
Prescient Tightens Governance With Updated Securities Trading Policy
TipRanks News
Neutral
Prescient widens half-year loss as R&D spend climbs but bolsters balance sheet
TipRanks News
Bearish
Prescient Wins EU Orphan Status for PTX‑100, Advances Global CTCL Trial and Cell Therapy Platforms
TipRanks News
Bullish
Prescient advances PTX-100 clinical program with key European regulatory wins
Proactive Investors
Bullish
Who will take out line honours as the ASX biotech winner of 2025?
StockHead
Neutral
PTX-100 gets EU green light for Phase 2 trial - ICYMI
Proactive Investors
Neutral
Prescient Therapeutics clears path to begin PTX-100 lymphoma trial in Italy
Proactive Investors
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:PTX’s Media Buzz Sentiment?
Currently, no data Available
What is AU:PTX’s weekly average amount of articles?
Currently, no data Available
What is AU:PTX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
OWLTOwlet
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week